FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. Issue 2 (February 2021)

• Record Type: Journal Article
• Authors: Tilanus-Linthorst, Madeleine; Geuzinge, A.; Obdeijn, I.M.; Rutgers, E.; Mann, R.; Saadatmand, S.; de Roy van Zuidewijn, D.; Oosterwijk, J.; Tollenaar, R.; Ausems, M.; van 't Riet, M.; Margrethe, S.V.; Hooning, M.; Wesseling, J.; Kristine, K.; Luiten, E.; Verhoef, C.; Heijnsdijk, E.; de Koning, H.
• Is Part Of: European journal of surgical oncology. Volume 47:Issue 2(2021)
• Page Start: e19
• Publication Date: 2021-02
• Subjects: Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2020.11.196
• Languages: English
• ISSNs: 0748-7983